Abstract 3799: Baseline Total Cholesterol Levels and Risk of Developing Brain Edema after Intravenous Thrombolysis in Acute Ischemic Stroke Patients

Stroke ◽  
2012 ◽  
Vol 43 (suppl_1) ◽  
Author(s):  
Svetlana Lorenzano ◽  
Niaz Ahmed ◽  
Karen L Furie ◽  
Nils Wahlgren ◽  
Danilo Toni

Objectives: There is evidence that low plasma cholesterol levels(CLs) are among the factors that contribute to blood brain barrier disruption in acute ischemic stroke, leading to hemorrhagic transformation.The aim of this was to evaluate the association between baseline CLs and the development of brain edema (BE)after i.v. thrombolysis in AIS. Methods: We analyzed all the data of AIS patients treated with i.v. rt-PA in Italy from 2003 to 2009 included in the international internet-based SITS-ISTR.The presence and severity of the BE was assessed on 22-36 hour and 7-day neuroimaging as mild, moderate and severe.Total CLs were obtained within 24 hours from symptom onset.Univariate and multivariate analyses were performed. Results: Overall, 4194 patients were included,of which 2577/4194 (61.4%) had data on baseline CLs.We analyzed CLs based on quartiles:≤164 mg/dl,≤191 mg/dl,≤221 mg/dl and >221 mg/dl. 1126/3782 (29.8%) developed BE within 22-36 hours of symptom onset,397 of 1015 (39.1%) at 7 days. In 103 cases (25.9%)BE developed between 36 hours and 7 days.Of 1126 patients with both 22-36 hour and 7-day neuroimaging, 89 (7.9%)had a BE worsening and 21 (1.9%)an improvement.Compared to those without BE,patients with BE were more likely to be dependent before stroke (p=0.031),have AF (p<0.0001),have early ischemic signs on baseline CT,higher prevalence of cardioembolic and large vessel mechanism,more SICH per NINDS definition,(p<0.0001).BE+ subjects had higher baseline median NIHSS(17 vs 11,p<0.0001), blood glucose levels (BGLs)(p=0.001) and DBP(p=0.044).Patients with BE had a worse outcome in terms of 3-month mRS>2 (72.5 vs 35.3%) and death (25.8 vs 6.7%) (p<0.0001).Subjects with BE were less likely to have a history of dyslipidemia (p=0.009).Independent predictors of BE developing within 22-36 hours were baseline NIHSS(OR1.104,95%CI 1.085-1.124,p<0.0001), BGLs(OR1.003,95%CI 1.001-1.005, p=0.014), onset-to-door time interval (OR1.002,95%CI 1.000-1.005,p=0.017), early ischemic signs on baseline CT (OR1.797,95%CI 1.127-2.867,p 0.014).NIHSS was confirmed as the strongest independent predictor for the presence of BE at the 7-day neuroimaging and for moderate and severe BE. BGLs was the only independent predictor of BE worsening (OR1.007,95%CI 1.000-1.014,p=0.05).Lower baseline CLs, in particular values <164 mg/dl,were independent predictors of BE improvement (OR3.758,95%IC 1.299-10.869,p=0.015)whereas higher values (>221 mg/dl) were independent predictors of severe BE at the 7-day neuroimaging (OR2.020,95%CI 1.044-3.94,p=0.037). Conclusions: Our study did not show an independent association between lower baseline total CLs and the risk of BE developing after i.v. thrombolysis in AIS. More studies are necessary to address this issue, particularly considering also the LDL-CLs and the use of statins at stroke onset and during the hospital stay.

2015 ◽  
Vol 8 (4) ◽  
pp. 342-346 ◽  
Author(s):  
Huan Tang ◽  
Sheng Zhang ◽  
Shenqiang Yan ◽  
David S Liebeskind ◽  
Jianzhong Sun ◽  
...  

ObjectiveTo assess the impact of diabetes on neurological outcome and recanalization in acute ischemic stroke (AIS) after intravenous thrombolysis (IVT).MethodsClinical data of 419 consecutive patients with AIS who received IVT between June 2009 and April 2014. Based on the medical history and new diagnosis, the patients were divided into groups with and without diabetes. Neurological outcomes at 24 h, 7 days and 3 months after IVT were evaluated. Favorable outcome was defined as National Institutes of Health Stroke Scale (NIHSS) score decrease ≥4 points from baseline or 0 at 24 h, NIHSS decrease ≥8 points or 0 at day 7, or modified Rankin scale ≤1 at 3 months after IVT. Recanalization on non-invasive imaging was evaluated in patients with large vessel occlusion (LVO) according to thrombolysis in myocardial infarction grades.ResultsAmong 419 patients, 98 (23.4%) had diabetes. Multivariable analyses showed that comorbidity of diabetes was an independent predictor of unfavorable outcome at 24 h (OR=0.534, 95% CI 0.316 to 0.903, p=0.019), at day 7 (OR=0.382, 95% CI 0.220 to 0.665, p=0.001), and at 3 months (OR=0.464, 95% CI 0.266 to 0.808, p=0.007). In patients with LVO, diabetes was an independent predictor of incomplete recanalization 24 h after IVT (OR=0.268, 95% CI 0.075 to 0.955, p=0.042).ConclusionsDiabetic patients with AIS had unfavorable neurological outcome, potentially linked to incomplete recanalization after IVT.


2021 ◽  
Vol 12 ◽  
Author(s):  
Haoye Cai ◽  
Honghao Huang ◽  
Chenguang Yang ◽  
Junli Ren ◽  
Jianing Wang ◽  
...  

Background and Purpose: The eosinophil-to-neutrophil ratio (ENR) was recently reported as a novel inflammatory marker in acute ischemic stroke (AIS). However, few studies reported the predictive value of ENR in AIS patients, especially for those with intravenous thrombolysis.Methods: Two hundred sixty-six AIS patients receiving intravenous thrombolysis were retrospectively recruited in this study and followed up for 3 months and 1 year. The Modified Rankin Scale (mRS) and the time of death were recorded. Poor outcome was defined as mRS 3–6. After excluding patients who were lost to follow-up, the remaining 250 patients were included in the 3-month prognosis analysis and the remaining 223 patients were included in the 1-year prognosis analysis.Results: ENR levels in the patients were lower than those in the healthy controls. The optimal cutoff values for the ability of ENR × 102 to predict 3-month poor outcome were 0.74 with 67.8% sensitivity and 77.3% specificity. Patients with ENR × 102 ≥ 0.74 have a lower baseline National Institutes of Health Stroke Scale (NIHSS) score (median: 7 vs. 11, p &lt; 0.001). After multivariate adjustment, patients with ENR × 102 ≥ 0.74 were more likely to come to a better 3-month outcome (OR = 0.163; 95% CI, 0.076–0.348, p &lt; 0.001). At the 1-year follow-up, the patients with ENR × 102 ≥ 0.74 showed a lower risk of mortality (HR = 0.314; 95% CI, 0.135–0.731; p = 0.007).Conclusions: A lower ENR is independently associated with a 3-month poor outcome and a 3-month and 1-year mortality in AIS patients treated with intravenous thrombolysis.


2019 ◽  
Author(s):  
Jie Liu ◽  
Jiaqi Huang ◽  
Huimin Xu ◽  
Haibin Dai

Abstract Background To investigate the factors associated with early neurological improvement of intravenous recombinant tissue plasminogen activator (rt-PA) treatment to acute ischemic stroke (AIS) within 4.5 hours of onset. Methods Demographics onset to treatment time, risk factors, and clinical and laboratory data of 209 AIS patients undergoing intravenous rt-PA therapy at the Second Affiliated Hospital, Zhejiang University School of Medicine between January 2013 and August 2016 were retrospectively analyzed. The National Institute of Health Stroke Scale (NIHSS) score was recorded before thrombolytic therapy, 24 h after the treatment and 7 d after the treatment to evaluate the recovery of neurological function. A multivariate logistic regression analysis was performed to assess the outcomes. Results Of the 209 AIS patients treated by intravenous thrombolysis with rt-PA. Low-density lipoprotein (LDL) levels were significantly lower (P < 0.05) in patients with early neurological improvement. The multivariable analysis showed that non-atrial fibrillation (AF) was independently associated with early neurological improvement at 24 h and 7 d after thrombolysis. Onset to treatment time was an independent predictor (P < 0.05) for early neurological improvement at 7 d after thrombolysis. The NIHSS score and diastolic blood pressure on admission were associated with symptomatic intracerebral hemorrhagic (sICH) transformation. Conclusions Non-AF was independently associated with early neurological improvement after intravenous thrombolysis in AIS patients, but non-AF was not associated with the occurrence of sICH. Onset to treatment time was an independent predictor of early neurological improvement at 7 d after thrombolysis in AIS patients.


PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0254253
Author(s):  
István Szegedi ◽  
Rita Orbán-Kálmándi ◽  
Attila Nagy ◽  
Ferenc Sarkady ◽  
Nikolett Vasas ◽  
...  

Background Intravenous thrombolysis using recombinant tissue plasminogen activator remains the mainstay treatment of acute ischemic stroke (AIS), although endovascular treatment is becoming standard of care in case of large vessel occlusions (LVO). To quantify the thrombus burden in LVO, a semiquantitative CT angiography (CTA) grading system, the clot burden score (CBS) can be used. Here we aimed to study the association between CBS and various hemostasis parameters, and to evaluate which parameters are major determinants of thrombolysis outcome. Methods In this single-centered prospective observational case-control study, 200 anterior circulation AIS patients receiving intravenous thrombolysis treatment without thrombectomy were enrolled: 100 AIS patients with LVO (CBS 0–9) and 100 age- and sex-matched AIS patients without LVO (CBS 10). Fibrinogen, α2-plasmin inhibitor, plasminogen, factor XIII and D-dimer were assessed from blood samples taken before and 24 h after thrombolysis, and FXIII-A Val34Leu was genotyped. CBS was calculated using admission CTA. Short-term outcomes were defined based on the change in NIHSS by day 7, long-term outcomes were assessed according to the modified Rankin scale at 3 months post-event. Results Poor outcomes were significantly more frequent in the CBS 0–9 group. Plasminogen activity on admission was significantly higher in the CBS 0–9 group. In a univariate analysis, significant protective effect of the Leu34 allele against developing larger clots (CBS 0–9) could be demonstrated (OR:0.519; 95%CI:0.298–0.922, p = 0.0227). Multivariate regression analysis revealed that CBS is an independent predictor of short- and long-term functional outcomes, while such effect of the studied hemostasis parameters could not be demonstrated. Conclusions CBS was found to be a significant independent predictor of thrombolysis outcomes. FXIII-A Leu34 carrier status was associated with smaller thrombus burden, which is consistent with the in vitro described whole blood clot mass reducing effects of the allele, but the polymorphism had no effect on thrombolysis outcomes.


2018 ◽  
Vol 67 (3) ◽  
pp. 659-662 ◽  
Author(s):  
Chien Tai Hong ◽  
Wei Ting Chiu ◽  
Nai Fang Chi ◽  
Le Yan Lai ◽  
Chaur Jong Hu ◽  
...  

Intravenous thrombolysis with the tissue plasminogen activator (tPA) is the gold standard for acute ischemic stroke. However, its application is limited because of the concern of the post-tPA intracranial hemorrhage (ICH). Low low-density lipoprotein (LDL) has been speculated to increase the risk of hemorrhagic transformation after ischemic stroke. However, whether LDL is associated with post-tPA ICH remains controversial. The present study obtained the medical records from Shuang Ho Hospital and retrospectively reviewed for the period between August 2009 and December 2016 to investigate the association between LDL and the risk of post-tPA ICH. The differences were analyzed using the Student’s t-test, Fisher’s exact test, the univariate and stepwise multiple regression model, and p<0.05 was considered statistically significant. Among 218 patients, post-tPA ICH was noted in 23 (10.5%) patients. Patients with post-tPA ICH tended to have a lower LDL level (ICH group: 102.00±24.56, non-ICH group: 117.02±37.60 mg/dL, p=0.063). However, after adjustment for the factors might affect the risk of post-tPA ICH, such as stroke severity, onset-to-treatment time interval, and atrial fibrillation (AF), LDL level was not associated with post-tPA ICH whereas AF was the only significant factor increased the risk of post-tPA ICH (adjusted OR: 1.177, 95% CI 1.080 to 1.283). In addition, patients with AF had significant lower LDL level and for patients without AF, LDL was not associated with the post-tPA ICH. In conclusion, LDL level is not associated with the risk of post-tPA ICH in Taiwanese patients with stroke.


2016 ◽  
Vol 13 (3) ◽  
pp. 193-198 ◽  
Author(s):  
Sabrina Anticoli ◽  
Maria Cristina Bravi ◽  
Giovanni Perillo ◽  
Antonio Siniscalchi ◽  
Claudio Pozzessere ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document